+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Humanized Mouse & Rat Model Market by Model Type (Humanized Rat Models, Immunodeficient Models, PDX Models), Application (Cardiovascular, Immunology, Infectious Disease), End User, Product Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5847087
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Organizations across life sciences are turning to advanced humanized mouse and rat models to optimize drug development and bridge the translation gap between laboratory research and clinical outcomes. Senior leaders are evaluating these models for their ability to accelerate innovation, enhance disease relevance, and address emerging market pressures.

Market Snapshot: Humanized Mouse & Rat Model Market

The Humanized Mouse & Rat Model Market grew from USD 275.91 million in 2024 to USD 297.24 million in 2025. It is expected to continue growing at a CAGR of 7.37%, reaching USD 422.90 million by 2030. This expansion is driven by rising investment in translational research, increasing demand for more predictive disease models, and technological advances in genome editing and immunodeficient animal strains. Leading pharmaceutical and biotechnology organizations are prioritizing these models as they seek to streamline preclinical programs and mitigate drug development risks. Enhanced by strong regional demand and collaboration across research ecosystems, the market supports a broad range of therapeutic discovery pipelines.

Scope & Segmentation

  • Model Types: Humanized rat models featuring hACE2 and hCD4, immunodeficient lines including NOG, NSG, and SCID, patient-derived xenograft (PDX) models for cancers, and transgenic knock-in/knock-out variants.
  • Applications: Solutions for cardiovascular, immunology, infectious disease, neurology, and oncology research—serving models for conditions such as atherosclerosis, autoimmune disorders, viral infections, neurodegeneration, and tumors.
  • End Users: Academic research institutes, contract research organizations (CROs), and pharmaceutical and biotech companies.
  • Product Types: Commercial and custom model products, as well as services for efficacy testing, model development, and screening.
  • Geographies: Americas (notably the United States, Canada, Brazil, and Mexico); Europe, Middle East & Africa (including UK, Germany, France, UAE, South Africa, and more); Asia-Pacific (notably China, Japan, India, Australia, and Southeast Asia).
  • Technologies: CRISPR/Cas9 genome editing, next-generation sequencing, patient-derived xenografting, advanced imaging, and computational model development.
  • Leading Providers: Charles River Laboratories International, The Jackson Laboratory, Taconic Biosciences, Inotiv, PerkinElmer, Crown Bioscience International, Biocytogen Pharmaceuticals, BioIVT, Cyagen Biosciences, and GemPharmatech.

Key Takeaways: Strategic Insights in the Humanized Mouse & Rat Model Market

  • Technical innovations and evolving research objectives are accelerating adoption of humanized models, offering more clinically relevant data for preclinical decision-making.
  • Integrated services by CROs and model suppliers streamline project timelines, reduce operational complexity, and foster reproducibility for multi-center studies.
  • Personalized medicine gains traction as patient-derived xenografts and targeted genetic modifications enable the study of tumor heterogeneity and treatment response.
  • Regional disparities in infrastructure, funding, and regulation influence adoption rates—particularly with robust ecosystems in the United States and dynamic growth in Asia-Pacific.
  • Expanded collaboration between industry leaders and academic centers facilitates rapid innovation and shared knowledge, supporting the development of advanced immunological and cancer models.
  • Emergence of data analytics and automation enhances the value of model systems, supporting predictive insights and scalability for complex disease research.

Tariff Impact on Supply Chain and Procurement Dynamics

Recent tariff measures in the United States have introduced new cost considerations for imported humanized animals and laboratory reagents, impacting procurement and supply chain strategies. Organizations are seeking domestic suppliers or local breeding partnerships to manage costs, necessitating investment in quality and compliance while adjusting sourcing approaches. Changing tariff structures have also prompted funding adjustments and increased emphasis on agile procurement teams, reinforcing the need for resilient, locally sourced ecosystems.

Methodology & Data Sources

This report leverages in-depth interviews with subject matter experts from academia, industry, and CROs, complemented by comprehensive secondary research of scientific literature, patent filings, and clinical registries. Rigorous data validation and triangulation ensure that segmentations and competitive insights reflect contemporary market realities.

Why This Report Matters

  • Helps senior decision-makers identify critical market shifts, operational challenges, and strategic growth areas in the humanized mouse and rat model landscape.
  • Enables targeted investment and partnership decisions by providing clarity on model utility, service innovations, and regional differentiation.
  • Empowers leadership teams to mitigate supply chain, regulatory, and tariff-related risks with up-to-date, actionable intelligence.

Conclusion

The humanized mouse and rat model market is advancing rapidly as research priorities, technology, and regional capabilities converge. By leveraging these developments, stakeholders can enhance translational relevance and drive therapeutic innovation in preclinical programs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in CRISPR/Cas9 engineered humanized mouse models enhancing immuno-oncology research reproducibility
5.2. Rising demand for humanized rat models to improve pharmacokinetic and toxicity profiling in preclinical studies
5.3. Integration of multi-omics and humanized rodent models to accelerate personalized medicine and biomarker discovery
5.4. Collaboration between biotech firms and academic institutions to develop next generation humanized rodent platforms
5.5. Expansion of humanized animal model services in emerging markets driven by growing biologics pipeline investments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Humanized Mouse & Rat Model Market, by Model Type
8.1. Introduction
8.2. Humanized Rat Models
8.2.1. hACE2 Rat Models
8.2.2. hCD4 Rat Models
8.3. Immunodeficient Models
8.3.1. NOG Models
8.3.2. NSG Models
8.3.3. SCID Models
8.4. PDX Models
8.4.1. Breast Cancer PDX
8.4.2. Colorectal Cancer PDX
8.4.3. Lung Cancer PDX
8.5. Transgenic Models
8.5.1. Knock-In Models
8.5.2. Knock-Out Models
9. Humanized Mouse & Rat Model Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Atherosclerosis Models
9.2.2. Hypertension Models
9.3. Immunology
9.3.1. Autoimmune Disorder Models
9.3.2. Inflammatory Disease Models
9.4. Infectious Disease
9.4.1. Bacterial Infection Models
9.4.2. Viral Infection Models
9.5. Neurology
9.5.1. Neurodegenerative Disease Models
9.5.2. Pain Models
9.6. Oncology
9.6.1. Hematological Models
9.6.2. Solid Tumor Models
10. Humanized Mouse & Rat Model Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical Biotech Companies
11. Humanized Mouse & Rat Model Market, by Product Type
11.1. Introduction
11.2. Model Products
11.2.1. Commercial Models
11.2.2. Custom Models
11.3. Services
11.3.1. Efficacy Testing Services
11.3.2. Model Development Services
11.3.3. Screening Services
12. Americas Humanized Mouse & Rat Model Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Humanized Mouse & Rat Model Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Humanized Mouse & Rat Model Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Charles River Laboratories International, Inc.
15.3.2. The Jackson Laboratory, Inc.
15.3.3. Taconic Biosciences, Inc.
15.3.4. Inotiv, Inc.
15.3.5. PerkinElmer, Inc.
15.3.6. Crown Bioscience International, Inc.
15.3.7. Biocytogen Pharmaceuticals Ltd.
15.3.8. BioIVT, Inc.
15.3.9. Cyagen Biosciences Inc.
15.3.10. GemPharmatech Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HUMANIZED MOUSE & RAT MODEL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUMANIZED MOUSE & RAT MODEL MARKET: RESEARCHAI
FIGURE 24. HUMANIZED MOUSE & RAT MODEL MARKET: RESEARCHSTATISTICS
FIGURE 25. HUMANIZED MOUSE & RAT MODEL MARKET: RESEARCHCONTACTS
FIGURE 26. HUMANIZED MOUSE & RAT MODEL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMANIZED MOUSE & RAT MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HACE2 RAT MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HACE2 RAT MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HCD4 RAT MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HCD4 RAT MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NOG MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NOG MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NSG MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NSG MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCID MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCID MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BREAST CANCER PDX, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BREAST CANCER PDX, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COLORECTAL CANCER PDX, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COLORECTAL CANCER PDX, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY LUNG CANCER PDX, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY LUNG CANCER PDX, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-OUT MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-OUT MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ATHEROSCLEROSIS MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ATHEROSCLEROSIS MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HYPERTENSION MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HYPERTENSION MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY AUTOIMMUNE DISORDER MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY AUTOIMMUNE DISORDER MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFLAMMATORY DISEASE MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFLAMMATORY DISEASE MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BACTERIAL INFECTION MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BACTERIAL INFECTION MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY VIRAL INFECTION MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY VIRAL INFECTION MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEURODEGENERATIVE DISEASE MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEURODEGENERATIVE DISEASE MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PAIN MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PAIN MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HEMATOLOGICAL MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HEMATOLOGICAL MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SOLID TUMOR MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SOLID TUMOR MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COMMERCIAL MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COMMERCIAL MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CUSTOM MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CUSTOM MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY EFFICACY TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY EFFICACY TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 181. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 182. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 183. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 184. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 185. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 186. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 187. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 188. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 189. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 190. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 191. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 194. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 195. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 198. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 199. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 200. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 201. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 208. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 209. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 210. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 224. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 225. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 240. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL PRODUCTS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Humanized Mouse & Rat Model market report include:
  • Charles River Laboratories International, Inc.
  • The Jackson Laboratory, Inc.
  • Taconic Biosciences, Inc.
  • Inotiv, Inc.
  • PerkinElmer, Inc.
  • Crown Bioscience International, Inc.
  • Biocytogen Pharmaceuticals Ltd.
  • BioIVT, Inc.
  • Cyagen Biosciences Inc.
  • GemPharmatech Co., Ltd.

Table Information